Last updated: February 23, 2026
What is the Drug Associated with NDC 72888-0103?
The National Drug Code (NDC) 72888-0103 corresponds to Sarsaparilla (sarsaparilla root extract), primarily marketed as a dietary supplement. This NDC is associated with a privately labeled product distributed by a supplement manufacturer, not an FDA-approved drug. Its primary use is in traditional medicine and alternative health practices, with no formal FDA approval for disease treatment.
Market Landscape
Industry Overview
The supplement market related to herbal and botanical products, including sarsaparilla, has grown steadily. The global herbal supplement market was valued at approximately USD 8-9 billion in 2020 and is projected to reach USD 13-15 billion by 2027, expanding at a compound annual growth rate (CAGR) of about 6-8% [1].
Key Market Segments
- Consumer Health: Consumers seeking natural remedies for skin conditions, inflammation, and hormonal balance.
- Sports Nutrition: Used as a component in natural supplements aimed at athletes.
- Cosmetics: Incorporated in topical formulations targeting skin health.
Competitor Analysis
Major players in herbal extracts include Gaia Herbs, Nature's Way, and NOW Foods. These companies distribute sarsaparilla either as a stand-alone product or as part of multi-herb formulations.
Regulatory Environment
The Dietary Supplement Health and Education Act (DSHEA) of 1994 governs herbal supplements in the US. These products do not require FDA approval before marketing but must meet Good Manufacturing Practices (GMP) and safety labeling standards.
Price Trends and Projections
Historical Pricing Data
- Retail prices in 2019-2022 for 60-100 capsules of sarsaparilla extract ranged from USD 10 to USD 25.
- Wholesale prices hover around USD 5-8 per bottle, depending on potency and brand.
Current Price Range
| Product Type |
Estimated Retail Price (USD) |
Average Wholesale Price (USD) |
| Standard herbal extract capsules |
12-20 |
5-8 |
| Organic, high-potency extracts |
20-25 |
8-12 |
| Multi-herb formulations |
15-25 |
7-12 |
Market Drivers
- Rising consumer preference for natural and herbal products.
- Growing interest in alternative health treatments.
- Limited clinical validation keeps large-scale prescription markets out.
Price Forecast (2023-2028)
Considering market expansion, regulatory pressures, and ingredient sourcing costs, price projections suggest:
- Retail prices may increase by 3-5% annually.
- Wholesale prices could see a 2-4% rise annually, particularly through sustainable sourcing and organic certification.
| Year |
Retail Price Range (USD) |
Wholesale Price Range (USD) |
| 2023 |
13-22 |
5.5-8.5 |
| 2025 |
15-27 |
6-9 |
| 2028 |
17-30 |
6.5-10 |
Factors influencing these projections include supply chain dynamics, raw material availability, and regulatory changes affecting herbal supplement classifications.
Regulatory and Legal Considerations Impacting Pricing
- FDA oversight: While not requiring pre-market approval, any health claims must comply with FDA regulations. Changes in compliance standards could increase manufacturing costs.
- FDA warning letters: Enforcement actions may increase costs if companies need to reformulate or modify labeling.
- International tariffs: Exporting herbal products to regions like EU or Asia involves tariffs influencing price competitiveness.
Strategic Market Entry Considerations
- Differentiation through organic certification or clinical studies may justify premium pricing.
- Partnership with established supplement brands can accelerate market penetration.
- Tiered pricing models might maximize reach across retail channels, from small health stores to large retail chains.
Summary
The market for sarsaparilla (NDC 72888-0103) remains niche, driven by consumer demand for herbal supplements. Prices are stable with slow upward trends, influenced by sourcing costs, regulatory compliance, and consumer perceptions of quality. Investment or expansion strategies should prioritize certification, supply chain stability, and consumer education.
Key Takeaways
- The herbal extract market is growing at 6-8% annually, with sarsaparilla positioned in the natural supplement niche.
- Retail prices are projected to grow 3-5% annually through 2028.
- Competition is primarily in private labels and small brands emphasizing organic and high-potency products.
- Regulatory factors could influence future costs, especially if FDA enforcement tightens.
- Strategic differentiation and brand positioning are critical for premium pricing.
FAQs
1. Is NDC 72888-0103 associated with an FDA-approved drug?
No. It corresponds to a herbal supplement, not an approved pharmaceutical. It is marketed as a dietary supplement under DSHEA regulations.
2. How does sourcing impact the price of sarsaparilla extracts?
Organic and sustainably sourced raw materials cost more, raising retail and wholesale prices. Scarcity of high-quality sarsaparilla also influences pricing.
3. What are the biggest risks to price growth?
Regulatory changes imposing stricter claims, rising raw material costs, and supply chain disruptions could slow price increases.
4. How does competition affect pricing strategies?
Private-label brands keep prices low, while brands emphasizing organic certification or clinical backing can command higher prices.
5. What are the future market opportunities?
Expanding consumer education, patenting unique formulations, and pursuing clinical validation may enable premium pricing and market share growth.
References
[1] Grand View Research. (2021). Herbal Supplements Market Size, Share & Trends Analysis Report. Retrieved from https://www.grandviewresearch.com/industry-analysis/herbal-supplements-market
